Sting Alumni, BrainZell, Gains Major Media Attention for Its Groundbreaking Neurological Innovation
Stockholm, Sweden – BrainZell, an innovative life sciences company and an alumnus of the Sting Incubate program was recently featured in one of Sweden's largest newspapers for its revolutionary work in medical research. The company’s breakthrough technology, which creates miniature models of the human brain, is set to transform the way we develop treatments for neurological disorders such as depression, Alzheimer's disease, and schizophrenia.